Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future

por Abramson, Hanley N.
Publicado 2023

Kinase inhibitors as potential agents in the treatment of multiple myeloma

por Abramson, Hanley N.
Publicado 2016

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update

por Abramson, Hanley N.
Publicado 2018

B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma

por Abramson, Hanley N.
Publicado 2020

Immunotherapy of Multiple Myeloma: Promise and Challenges

por Abramson, Hanley N
Publicado 2021

Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma

por Abramson, Hanley N.
Publicado 2023

The stress of starvation: glucocorticoid restraint of beta cell development

por Matthews, L. C., Hanley, N. A.
Publicado 2010

What a Difference a Stochastic Process Makes: Epidemiological-Based Real Options Models of Optimal Treatment of Disease

por Dangerfield, C. E., Whalley, A. E., Hanley, N., Gilligan, C. A.
Publicado 2017

Chemical nature and immunotoxicological properties of arachidonic acid degradation products formed by exposure to ozone.

por Madden, M C, Friedman, M, Hanley, N, Siegler, E, Quay, J, Becker, S, Devlin, R, Koren, H S
Publicado 1993

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration

por Holton, C. M., Hanley, N., Shanks, E., Oxley, P., McCarthy, A., Eastwood, B. J., Murray, T. K., Nickerson, A., Wafford, K. A.
Publicado 2020